Rahul Sharma

Dr. Rahul Sharma


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2019 in Hepatology
Verified
Journal Article
Closed access
PDF file
TMTakashi Matsuzaka
Takashi Matsuzaka
MKMotoko Kuba
Motoko Kuba
SKSaori Koyasu
Saori Koyasu
YYYuta Yamamoto
Yuta Yamamoto
KMKaori Motomura
Kaori Motomura
HSHitoshi Shimano
Hitoshi Shimano

26 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RSRahul Sharma
Rahul Sharma
TMTakashi Matsuzaka
Takashi Matsuzaka
MKMahesh K. Kaushik
Mahesh K. Kaushik
TSTakehito Sugasawa
Takehito Sugasawa
HOHiroshi Ohno
Hiroshi Ohno
HSHitoshi Shimano
Hitoshi Shimano
Brown adipose tissue (BAT) is an attractive therapeutic target for treating obesity and metabolic diseases. Octacosanol is the main component of policosanol, a mixture of very long chain aliphatic alcohols obtained from plants. The current study aimed to investigate the effect of octacosanol and policosanol on high-fat diet (HFD)-induced obesity. Mice were fed on chow, or HFD, with or without octacosanol or policosanol treatment for four weeks. HFD-fed mice showed significantly higher body weight and body fat compared with chow-fed mice. However, mice fed on HFD treated with octacosanol or policosanol (HFDo/p) showed lower body weight gain, body fat gain, insulin resistance and hepatic lipid content. Lower body fat gain after octacosanol or policosanol was associated with increased BAT activity, reduced expression of genes involved in lipogenesis and cholesterol uptake in the liver, and amelioration of white adipose tissue (WAT) inflammation. Moreover, octacosanol and policosanol significantly increased the expression of Ffar4, a gene encoding polyunsaturated fatty acid receptor, which activates BAT thermogenesis. Together, these results suggest that octacosanol and policosanol ameliorate diet-induced obesity and metabolic disorders by increasing BAT activity and improving hepatic lipid metabolism. Thus, these lipids represent promising therapeutic targets for the prevention and treatment of obesity and obesity-related metabolic disorders.

1 June 2018 in Endocrinology
Verified
Journal Article
Closed access
PDF file
HOHiroshi Ohno
Hiroshi Ohno
TMTakashi Matsuzaka
Takashi Matsuzaka
NTNie Tang
Nie Tang
RSRahul Sharma
Rahul Sharma
KMKaori Motomura
Kaori Motomura
HSHitoshi Shimano
Hitoshi Shimano
Sterol regulatory element-binding protein (SREBP)-1a is a key transcription factor that activates the expression of genes involved in the synthesis of fatty acids, triglycerides (TGs), and cholesterol. Transgenic mice that overexpress the nuclear form of SREBP-1a under the control of the phosphoenolpyruvate carboxykinase promoter (Tg-1a) were previously shown to display a lipodystrophic phenotype characterized by enlarged and fatty livers, diminished peripheral white adipose tissue (WAT), and insulin resistance. In the current study, we crossed these Tg-1a mice with genetically obese (ob/ob) mice (Tg-1a; ob/ob) and examined change in fat distribution between liver and adipose tissues in severe obesity and mechanism underlying the lipodystrophic phenotype in mice with Tg-1a. Tg-1a; ob/ob mice developed more severe steatohepatitis but had reduced WAT mass and body weight compared with ob/obmice. The reduction of WAT mass in Tg-1a and Tg-1a; ob/obmice was accompanied by enhanced lipogenesis and lipid uptake in the liver, reduced plasma lipid levels, impaired adipocyte differentiation, reduced food intake, enhanced energy expenditure, and extended macrophage infiltration and fibrosis in WAT. Despite the improved glucose tolerance, Tg-1a; ob/ob mice showed severe peripheral insulin resistance. Adenoviral hepatic expression of SREBP-1a mimicked these phenotypes. The "fat steal"-like lipodystrophy phenotype of the Tg-1a;ob/ob model demonstrates that hepatic SREBP-1a activation has a strong impact on the partition of TG accumulation, resulting in adipose-tissue remodeling by inflammation and fibrosis and insulin resistance.

Verified
Journal Article
Open access
PDF file
Takehito SugasawaTakehito Sugasawa
Takehito Sugasawa
YTYoshiya Tome
Yoshiya Tome
YTYoshinori Takeuchi
Yoshinori Takeuchi
YYYasuko Yoshida
Yasuko Yoshida
NYNaoya Yahagi
Naoya Yahagi
KTKazuhiro Takekoshi
Kazuhiro Takekoshi
Local cryotherapy is widely used as a treatment for sports-related skeletal muscle injuries. The molecular mechanisms are unknown. To clarify these mechanisms, we applied one to three 15-min cold stimulations at 4 °C to various cell lines (in vitro), the tibialis anterior (TA) muscle (ex vivo), and mouse limbs (in vivo). In the in vitro assay, cyclic AMP (cAMP) response element binding protein 1 (CREB1) was markedly phosphorylated (p-CREB1), and the CREB-binding protein (CBP) was recruited to p-CREB-1 in response to two or three cold stimulations. In a reporter assay with the cAMP-responsive element, the signals significantly increased after two to three cold stimulations at 4 °C. In the ex vivo study, CREB-targeting genes were significantly upregulated following two or three cold stimulations. The in vivo experiment disclosed that cold stimulation of a mouse limb for 9 days significantly increased mitochondrial DNA copy number and upregulated genes involved in mitochondrial biogenesis. The results suggest that local cryotherapy increases CREB transcription and upregulates CREB-targeting genes, in a manner dependent on cold stimulation frequency and duration. This information will inform further investigations into local cryotherapy as a treatment for sports-related skeletal muscle trauma.

1 November 2018 in Neuroscience Letters
Verified
Journal Article
Closed access
Mahesh Kumar KaushikMahesh Kumar Kaushik
Mahesh Kumar Kaushik
KAKosuke Aritake
Kosuke Aritake
YCYoan Cherasse
Yoan Cherasse
RSRahul Sharma
Rahul Sharma
YUYoshihiro Urade
Yoshihiro Urade